International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 0 | Views: 91

Research Paper | Orthopedic | India | Volume 11 Issue 10, October 2022

Autologus Platelet Rich Plasma a Biological Therapeutic Option for Planter Fascitis

Khajotia B. L. | Singh Chandan | Tanwar Sanjay | Grover Kheman

Abstract: Introduction: Plantar fasciitis (PF) is a common lesion that occurs in the heel, and approximately 11% to 15% of adult foot symptoms require professional care. In terms of treatment, various methods have also been used in the treatment of PF, including nonsteroidal anti - inflammatory drugs (NSAIDs), corticosteroid injections, and nondrug approaches, such as ice packs, shoe inserts, plantar fascia stretching exercises, extracorporeal shock wave therapy, and even surgical treatment. Over the last few years, the use of autologous platelet - rich plasma (PRP) has emerged in the forefront of biologic tools for foot and ankle specialists. Platelet - rich plasma (PRP) has been used as an alternative therapy for plantar fasciitis (PF) to reduce heel pain and improve functional restoration. Methodology: A hospital - based prospective case study of 30 unilateral plantar fasciitis patients with symptom duration of 6 months or more was done. All patients included in the study were assessed clinically, by visual analogue score for heel pain and by Foot and Ankle Disability Index (FADI) score for functional outcome at 2, 4, 12 and 24 weeks follow - up. All patients were observed for 24 weeks. Results: The mean age was 42.3 years (range 28 - 65 years). The pre - injection mean VAS score for heel pain was 5.67 ? 1.49 which improved upto 3.6?1.42 at 2 weeks, 2.0?0.10 at 4 weeks, 0.6?0.9 at 12 weeks and.06?.03 at 24 week respectively. The baseline mean FADI scores were 60.58?5.57 which improved to 65.05?5.74 at 2 weeks, 68.27?5.90 at 4 weeks, 71.11?6.92 at 12 weeks and 73.54?6.56 at 24 weeks respectively. Conclusion: The short - term results of single dose PRP injection have shown clinical improvements in VAS for heel pain and functional outcome scores. This study concludes that local PRP injection is a viable management option for chronic plantar fasciitis.

Keywords: Foot and Ankle Disability Index, Plantar Fasciitis, Platelet Rich Plasma, Non Steroidal Anti - Inflammatory Drugs, Visual Analogue Scale.

Edition: Volume 11 Issue 10, October 2022,

Pages: 994 - 997

How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link

Verification Code will appear in 2 Seconds ... Wait